Tubeless Insulin Pump Market - By End-use (Homecare, Hospitals & Clinics), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023

Description

List of Tables

Global Tubeless Insulin Pump Market will register a 19.2% CAGR from 2023 to 2032, propelled by increasing awareness of advanced insulin delivery options and technological innovations in pump design. As individuals and healthcare providers become more conscious of streamlined and patient-friendly solutions, demand for tubeless insulin pumps will surge. Technological advancements, offering enhanced features and user convenience, further contribute to market expansion. The synergy between rising awareness and continuous innovation will position tubeless insulin pumps as pivotal components in the evolving landscape of diabetes care, propelling the market's upward trajectory.

Companies are actively working on creating solutions for individuals with diabetes. This commitment to innovation enhances the tubeless insulin pump market by expanding the range of advanced and patient-friendly options, promoting accessibility, and improving overall diabetes care. For instance, in 2023, Insulet officially introduced the Omnipod 5 automated insulin delivery system, offering simplified glucose management without the need for multiple daily injections, tubes, or fingersticks.

The tubeless insulin pump industry is bifurcated based on end-use and region.

The hospitals and clinics end-use segment will achieve remarkable market share by 2032, driven by the increasing integration of advanced diabetes management technologies in healthcare settings. As hospitals and clinics prioritize efficient and patient-friendly solutions, the demand for tubeless insulin pumps will surge. The pivotal role of healthcare providers in promoting and implementing innovative diabetes care solutions will position this segment as a major contributor to the expanding landscape of tubeless insulin pump adoption.

Asia-Pacific tubeless insulin pump market will grow at a noteworthy CAGR from 2023 to 2032, attributed to the region's increasing prevalence of diabetes, growing healthcare infrastructure, and rising awareness about advanced diabetes management technologies. The demand for tubeless insulin pumps is notably high, driven by the convenience they offer in insulin delivery and continuous glucose monitoring. As healthcare systems in Asia-Pacific prioritize diabetes care, the region will play a pivotal role in shaping the trajectory and expansion of the tubeless insulin pump industry.

Product Code: 2032

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Tubeless insulin pump industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 End-use trends

Chapter 3 Tubeless Insulin Pump Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of diabetes
  - 3.2.1.2 Technological advancements in tubeless insulin pump
  - 3.2.1.3 Increasing diabetes care expenditure
  - 3.2.1.4 Injuries caused by conventional & invasive insulin pumps
  - 3.2.1.5 Adoption of facilitative initiatives
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High long-term costs associated with tubeless insulin pump
  - 3.2.2.2 Stringent government regulations
3.3 Growth potential analysis
- 3.3.1 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Reimbursement scenario
3.7 Technology landscape
3.8 Incidence & prevalence of diabetes
3.9 Pipeline analysis
3.10 Future market trends
3.11 Gap analysis
3.12 Porter's analysis
3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis, 2022
4.6 Strategy dashboard, 2022

Chapter 5 Tubeless Insulin Pump Market Size and Forecast, By End-use (USD Million)

5.1 Key trends, by end-use
5.2 Home care
5.3 Hospitals & clinics
5.4 Others

Chapter 6 Tubeless Insulin Pump Market Size and Forecast, By Region (USD Million)

6.1 Key trends, by region
6.2 North America
- 6.2.1 U.S.
- 6.2.2 Canada
6.3 Europe
- 6.3.1 Germany
- 6.3.2 UK
- 6.3.3 France
- 6.3.4 Spain
- 6.3.5 Italy
6.4 Asia Pacific
- 6.4.1 Japan
- 6.4.2 China
- 6.4.3 Australia
- 6.4.4 South Korea
6.5 RoW

Chapter 7 Company Profiles

7.1 Insulet Corporation
7.2 Roche
7.3 Medtrum Technologies
7.4 Terumo Corporation
7.5 Mannkind Corporation
7.6 Terumo Corporation